4//SEC Filing
Johnson Anne Nagengast 4
Accession 0001140361-25-009510
CIK 0001840904other
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 7:29 PM ET
Size
6.7 KB
Accession
0001140361-25-009510
Insider Transaction Report
Form 4
Johnson Anne Nagengast
Chief Financial Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2025-03-14−100,000→ 0 total→ Common Shares (100,000 underlying) - Exercise/Conversion
Common Shares
2025-03-14+100,000→ 173,590 total
Footnotes (1)
- [F1]Each restricted stock unit represents a contingent right to receive one common share of the Issuer upon vesting and settlement. 50% of the restricted stock units vested on March 14, 2024, the first anniversary of the grant date and 50% vested on March 14, 2025, the second anniversary of the grant date.
Documents
Issuer
ATAI Life Sciences N.V.
CIK 0001840904
Entity typeother
Related Parties
1- filerCIK 0001976640
Filing Metadata
- Form type
- 4
- Filed
- Mar 18, 8:00 PM ET
- Accepted
- Mar 19, 7:29 PM ET
- Size
- 6.7 KB